BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao F, Hobson AR, Shang ZM, Pei YX, Gao Y, Wang JX, Huang WN. The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis. BMC Gastroenterol 2015;15:26. [PMID: 25881023 DOI: 10.1186/s12876-015-0253-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Ghebre YT, Raghu G. Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs. Am J Respir Crit Care Med 2016;193:1345-52. [PMID: 27110898 DOI: 10.1164/rccm.201512-2316PP] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 9.4] [Reference Citation Analysis]
2 Ghisa M, Marinelli C, Savarino V, Savarino E. Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag 2019;15:1081-93. [PMID: 31564886 DOI: 10.2147/TCRM.S184291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Herbella FAM, Patti MG. Gastroesophageal Reflux Disease and Idiopathic Lung Fibrosis. From Heartburn to Lung Transplant, and Beyond. Am Surg 2021;:3134821998686. [PMID: 33629881 DOI: 10.1177/0003134821998686] [Reference Citation Analysis]
4 Houghton LA, Lee AS, Badri H, DeVault KR, Smith JA. Respiratory disease and the oesophagus: reflux, reflexes and microaspiration. Nat Rev Gastroenterol Hepatol 2016;13:445-60. [PMID: 27381074 DOI: 10.1038/nrgastro.2016.91] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
5 Man L, Hong P. Idiopathic Pulmonary Fibrosis: A Systemic Disease? Chin Med J (Engl) 2017;130:2140-1. [PMID: 28836568 DOI: 10.4103/0366-6999.213423] [Reference Citation Analysis]
6 Baqir M, Vasirreddy A, Vu AN, Moua T, Chamberlain AM, Frank RD, Ryu JH. Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study. Respir Med 2021;178:106309. [PMID: 33517156 DOI: 10.1016/j.rmed.2021.106309] [Reference Citation Analysis]
7 Singh S, Sharma BB, Bairwa M, Gothi D, Desai U, Joshi JM, Talwar D, Singh A, Dhar R, Sharma A, Ahluwalia B, Mangal DK, Jain NK, Pilania K, Hadda V, Koul PA, Luhadia SK, Swarnkar R, Gaur SN, Ghoshal AG, Nene A, Jindal A, Jankharia B, Ravindran C, Choudhary D, Behera D, Christopher DJ, Khilnani GC, Samaria JK, Singh H, Gupta KB, Pilania M, Gupta ML, Misra N, Singh N, Gupta PR, Chhajed PN, Kumar R, Chawla R, Jenaw RK, Chawla R, Guleria R, Agarwal R, Narsimhan R, Katiyar S, Mehta S, Dhooria S, Chowdhury SR, Jindal SK, Katiyar SK, Chaudhri S, Gupta N, Singh S, Kant S, Udwadia Z, Singh V, Raghu G. Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP). Lung India 2020;37:359-78. [PMID: 32643655 DOI: 10.4103/lungindia.lungindia_275_20] [Reference Citation Analysis]
8 Chen S, Chen H, Cheng Y, Wei Y, Zhou X, Li T, Zhu J, Wang Q. Gastric Acid and Pepsin Work Together in Simulated Gastric Acid Inhalation Leading to Pulmonary Fibrosis in Rats. Med Sci Monit 2019;25:6153-64. [PMID: 31419218 DOI: 10.12659/MSM.915628] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Woods DF, Flynn S, Caparrós-Martín JA, Stick SM, Reen FJ, O'Gara F. Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung. Antibiotics (Basel) 2021;10:766. [PMID: 34202495 DOI: 10.3390/antibiotics10070766] [Reference Citation Analysis]
10 Dziekiewicz MA, Karolewska-bochenek K, Dembiński Ł, Gawronska A, Krenke K, Lange J, Banasiuk M, Kuchar E, Kulus M, Albrecht P, Banaszkiewicz A. Gastroesophageal Reflux Disease in Children with Interstitial Lung Disease. In: Pokorski M, editor. Prospect in Pediatric Diseases Medicine. Cham: Springer International Publishing; 2016. pp. 57-64. [DOI: 10.1007/5584_2016_229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Lee CM, Lee DH, Ahn BK, Hwang JJ, Yoon H, Shin CM, Park YS, Kim N. Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil 2016;22:444-51. [PMID: 26932897 DOI: 10.5056/jnm15192] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
12 King CS, Nathan SD. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. The Lancet Respiratory Medicine 2017;5:72-84. [DOI: 10.1016/s2213-2600(16)30222-3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 39] [Article Influence: 16.2] [Reference Citation Analysis]
13 Akiyama J, Kuribayashi S, Baeg MK, Bortoli N, Valitova E, Savarino EV, Kusano M, Triadafilopoulos G. Current and future perspectives in the management of gastroesophageal reflux disease. Ann N Y Acad Sci 2018;1434:70-83. [DOI: 10.1111/nyas.13850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cheah R, Chirnaksorn S, Abdelrahim AH, Horgan L, Capstick T, Casey J, Peckham D, Boland A, Sutherland TJT, Beirne P, Lee AS, DeVault KR, Houghton LA. The Perils and Pitfalls of Esophageal Dysmotility in Idiopathic Pulmonary Fibrosis. Am J Gastroenterol 2021;116:1189-200. [PMID: 34074825 DOI: 10.14309/ajg.0000000000001202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]